FDA warning letter
Closeout letter
Issue date
25 Mar 2020
Issuing office
Center for Drug Evaluation and Research | CDER
Posted date
31 Mar 2020
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
Issue date
10 Feb 2023
Pfizer
Manufacturer
Audited
Warning letter
Headquarters
United States of AmericaSites
United States of America
Ireland
Singapore
Belgium
Italy
Puerto Rico
India
People's Republic of China
Canada
Germany